MedPath

Exciton Technologies Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Non-healing Diabetic Foot Ulcer
Diabetic Foot Infection
Diabetic Foot Ulcer
Interventions
Device: EPC Silver Wound Gel
First Posted Date
2022-02-17
Last Posted Date
2023-09-22
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
5
Registration Number
NCT05243810
Locations
🇨🇦

Lawson Health Research Institute, London, Ontario, Canada

Impact of Oxidized Silver Wound Dressings on Wound Bacteria

Not Applicable
Completed
Conditions
Wounds
Interventions
Device: Exsalt SD7, Exsalt T7 Wound Dressing
First Posted Date
2016-01-25
Last Posted Date
2016-01-25
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
17
Registration Number
NCT02662101

Trial of exSALT SD7™ Compared to Xeroform® Petrolatum Dressing for the Management of Partial Thickness Donor Sites

Not Applicable
Conditions
Wound Healing
Wound Infection
Interventions
Device: The exSALT™ SD7 Wound Dressing
Device: Xeroform® Petrolatum Dressing
First Posted Date
2009-08-31
Last Posted Date
2009-12-24
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
25
Registration Number
NCT00968994
Locations
🇨🇦

The University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath